Expression of EgfrU.A887T.Scer\UAS under the control of Scer\GAL4esg-NP5130 (in combination with a Gal80[ts] transgene to restrict expression to the adult stage) results in a significant increase in the number of mitotic cells in the midgut, as compared to controls.
Adult Scer\GAL4tin.CΔ4>EgfrU.A887T.Scer\UAS flies have smaller heart chambers with reduced end-diastolic dimensions compared with controls. Histological analysis of cardiac chambers from the adult transgenic flies show heart wall thicknesses that are two to three times compared with controls. Hearts isolated from the transgenic flies show abnormal cardiac morphology with myofiber disarray compared with controls. The number of cells in the transgenic hearts is similar to that in wild-type, indicating that the increased wall thickness is the result of cardiomyocyte hypertrophy, not an increase in cell proliferation.
Expression of EgfrU.A887T.Scer\UAS in differentiating eye cells driven by Scer\GAL4GMR.PU causes rough eyes of reduced size.
Expression of EgfrU.A887T.Scer\UAS under the control of Scer\GAL4sim.P3.7 results in an increased number of midline glia cells compared to wild type at stage 16 of embryogenesis.
Flies expressing EgfrU.A887T.Scer\UAS under the control of Scer\GAL4bbg-C96 have notches on the posterior half of the wing margin.
EgfrU.A887T.UAS, Scer\GAL4GMR.PU has visible phenotype, enhanceable by Rabex-5VDRC.cUa, Scer\GAL4GMR.PU
EgfrU.A887T.UAS, Rabex-5VDRC.cUa, Scer\GAL4GMR.PU has lethal phenotype
EgfrU.A887T.UAS, Scer\GAL4GMR.PU has eye phenotype, enhanceable by Rabex-5VDRC.cUa, Scer\GAL4GMR.PU
EgfrU.A887T.UAS, Scer\GAL4sim.P3.7 has midline glial cell | increased number | embryonic stage 16 phenotype, non-suppressible by Rat\NeuKDYD.UAS, Scer\GAL4sim.P3.7
Co-expression of bunGD1392 or MadmGD7155 suppresses the increased number of mitotic cells seen in the midguts of flies expressing EgfrU.A887T.Scer\UAS under the control of Scer\GAL4esg-NP5130.
Co-expression of Rabex-5VDRC.cUa significantly enhances the number of eyes with black tissue and significantly increases lethality resulting from the expression of EgfrU.A887T.Scer\UAS driven by Scer\GAL4GMR.PU.
Co-expression of Rat\NeuKDYD.Scer\UAS does not significantly reduce the increased number of midline glia cells at stage 16 of embryogenesis which are seen in animals expressing EgfrU.A887T.Scer\UAS under the control of Scer\GAL4sim.P3.7.
This line is originally from the Bloomington Stock Center, so it could correspond to either Egfr1.A887T.Scer\UAS or Egfr2.A887T.Scer\UAS.